Erythra-derm

Erythra-derm

Erythra-derm Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

The safe use of Erythromycin Topical Solution during pregnancy or lactation has not been established.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Erythromycin Topical Solution is indicated for the topical control of acne vulgaris.

History

There is currently no drug history available for this drug.

Other Information

Erythromycin is an antibiotic produced from a strain of Streptomyces erythraeus. It is basic and readily forms salts with acids.

Chemically, erythromycin is (3R*, 4S*, 5S*, 6R*, 7R*, 9R*, 11R*, 12R*, 13S*, 14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-0-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2, 10-dione with a molecular formula of C37H67NO13 and a molecular weight of 733.94. The structural formula is as follows:

Chemical Structure

Erythromycin Topical Solution USP 2% contains 20 mg/mL of erythromycin base in a vehicle consisting of alcohol (66%), propylene glycol, and citric acid to adjust pH.

Erythra-derm Manufacturers


  • Paddock Laboratories, Inc.
    Erythra-derm (Erythromycin) Solution [Paddock Laboratories, Inc.]

Login To Your Free Account